Welcome to Standard Medical Shop

HomeShopA-ZDIAMPA LT 25MG +5 MG TAB

DIAMPA LT 25MG +5 MG TAB

 755

Add to wishlist Add to compare
Categories: ,

Description

Empagliflozin Sodium-glucose co-transporter 2 (SGLT2) is the predominant transporter responsible for reabsorption of glucose from the glomerular filtrate back into the circulation. Empagliflozin is an inhibitor of SGLT2. By inhibiting SGLT2, Empagliflozin reduces renal reabsorption of filtered glucose and lowers the renal threshold for glucose, and thereby increases urinary glucose excretion. Linagliptin Linagliptin is an inhibitor of DPP-4, an enzyme that degrades the incretin hormones glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). Thus, Linagliptin increases the concentrations of active incretin hormones, stimulating the release of insulin in a glucose-dependent manner and decreasing the levels of glucagon in the circulation. Both incretin hormones are involved in the physiological regulation of glucose homeostasis. GLP-1 and GIP increase insulin biosynthesis and secretion from pancreatic beta cells in the presence of normal and elevated blood glucose levels. Furthermore, GLP-1 also reduces glucagon secretion from pancreatic alpha cells, resulting in a reduction in hepatic glucose output.

Reviews

There are no reviews yet.

Be the first to review “DIAMPA LT 25MG +5 MG TAB”

Your email address will not be published. Required fields are marked *

Need help..?
Call Us At:

0544-624301
0303-8510111

Copyright 2024 Standard. All Rights Reserved